Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Interscalene versus anterior suprascapular nerve blocks to prevent shoulder pain after open lung surgery

Official title: Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain: A Randomized Controlled Trial

Run by National Cancer Institute, Egypt · NCT07424638 · Data updated 2026-11-12

This trial will test whether adding an ultrasound-guided interscalene block or an anterior suprascapular block to epidural anesthesia reduces shoulder pain after thoracotomy in adults with lung cancer.

More Shoulder Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment75 (estimated)
SponsorNational Cancer Institute, Egypt
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedFebruary 21, 2026
Main results expectedJuly 30, 2026
Study endsJuly 30, 2026
Registry record updatedFebruary 24, 2026
Trial IDNCT07424638 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18–65 with confirmed lung cancer scheduled for elective open-lung surgery, ASA II–III, BMI 18–35 kg/m2, and no contraindications to regional anesthesia.

Probably not a fit

Patients with pre-existing shoulder symptoms, contraindications to blocks (such as coagulopathy, local infection, or allergy to local anesthetics), severe restrictive or obstructive lung disease, prior thoracotomy, or contralateral diaphragmatic paralysis are unlikely to benefit or may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with lung cancer scheduled for elective open thoracotomy will be assigned to receive either an interscalene block plus epidural, an anterior suprascapular block plus epidural, or epidural analgesia alone. The peripheral nerve blocks are performed under ultrasound guidance in the perioperative period and patients are monitored for postoperative pain outcomes and complications. The primary outcome is the frequency of ipsilateral shoulder pain after thoracotomy, with additional measures of analgesic use and recovery recorded during follow-up. The design compares the added benefit of each block to standard epidural care to determine if either technique reduces the common problem of post-thoracotomy shoulder pain.

Why it matters

Potential benefit: If successful, adding one of these nerve blocks could lower the rate of post-thoracotomy shoulder pain, improve breathing and physiotherapy participation, and accelerate recovery while possibly reducing opioid needs.

How similar studies have gone: Previous smaller studies and case series suggest interscalene and suprascapular blocks can reduce postoperative shoulder pain, but results are mixed and direct head-to-head comparisons with epidural-only care remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 years and ≤ 65 years old.
* American Society of Anesthesiologists (ASA) physical status II-III.
* Body mass index 18-35 kg/m2.
* Patients who have a confirmed diagnosis of lung cancer and are scheduled for elective open-lung surgery.

Exclusion Criteria:

* Allergy to local anesthetics.
* Known psychiatric or neurologic disorders.
* Alcohol or narcotics abuse.
* Contraindications to thoracic epidural or suprascapular block, or interscalene block, e.g., coagulopathy or local infection.
* Pre-existing shoulder symptoms.
* History of previous thoracotomy.
* Severe restrictive or obstructive pulmonary disease.
* Pre-existing contralateral diaphragmatic paralysis.

Where it's running

  • Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.